Involvement of functional antagonism in the effects of adenosine antagonists and L-NAME in the rat isolated heart

General Pharmacology

Volumn 29, Issue 3, 1997, Pages 421-427

  Lewis, C D ^a,b   Hourani, S M O ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

Adenosine; L NAME; Langendorff; Purinoceptor; Rat heart

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 6 N CYCLOPENTYLADENOSINE; 8 (4 SULFOPHENYL)THEOPHYLLINE; ADENOSINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2 RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; N [2 (DIMETHYLAMINO)ETHYL] N METHYL 4 (1,3 DIPROPYLXANTHIN 8 YL)BENZENESULFONAMIDE; N(G) NITROARGININE METHYL ESTER;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FLOW RATE; HEART; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADENOSINE; ADENOSINE-5'-(N-ETHYLCARBOXAMIDE); ADRENERGIC ALPHA-AGONISTS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ENZYME INHIBITORS; HEART; HEART ATRIA; MALE; MYOCARDIAL CONTRACTION; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE; PHENETHYLAMINES; PHENYLEPHRINE; PURINES; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P1; SULFONAMIDES; THEOPHYLLINE; VASODILATOR AGENTS;

EID: 0030804108     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(96)00466-1     Document Type: Article

References (16)

1. Brackett L. E. and Daly J. W. (1991) Relaxant effects of adenosine analogs on guinea-pig trachea in vitro: xanthine-sensitive and xanthine-insensitive mechanisms. J. Pharmac. Exp. Ther. 257, 205-213.
2. Brady A. J. B., Warren J. B., Poole-Wilson P. A., Williams T. J. and Harding S. E. (1993) Nitric oxide attenuates cardiac myocyte contraction. Am. J. Physiol. 265, H176-H182.
3. 2 receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 335, 64-69.
4. 3H]-NECA in the rat striatal membrane. Mol Pharmacol., 29, 331-346.
5. Collis M. G. and Hourani, S. M. O. (1993). Adenosine receptor subtypes. Trends in Pharmacol. Sci. 14, 360-366.
6. Cristalli G., Vittori S., Thompson R. D., Padgett W. L., Shi D., Daly J. W. and Olsson R. A. (1994) Inhibition of platelet aggregation by adenosine receptor agonists. Naunyn-Schmiedeberg's Arch. Pharmacol. 349, 644-650.
7. 2 adenosine receptors coupled to adenylate cyclase. Biochem Pharmacol. 43, 1089-1093.
8. Gurden M. F., Coates J., Ellis F., Evans B., Foster M., Hornby E., Kennedy I., Martin D. P., Strong P., Vardey C. J. and Wheeldon A. (1993) Functional characterization of three adenosine receptor types. Br. J. Pharmacol. 109, 693-698.
9. Hamilton H. W., Taylor, M. D., Steffen R. P., Haleen S. J. and Bruns R. F. (1987) Correlation of adenosine receptor affinities and cardiovascular activity. Life Sci. 41, 2295-2302.
10. 2) receptors. In Adenosine and Adenine Nucleotides: From molecular biology to integrative physiology. (Edited by Belardinelli L. and Pelleg A.) pp. 5-13. Kluwer Academic Press, Boston.
11. Lewis C. D., Hourani S. M. O., Long C. J. and Collis M. G. (1994) Characterization of adenosine receptors in the rat isolated aorta. Gen. Pharmacol. 25, 1381-1387.
12. 2 receptor agonists CGS 21680 and COS 22492 in human vasculature. Eur. J. Pharmacol. 221, 242-247.
13. 2 receptors of adenosine agonists and antagonists and their effects on heart rate and cardiovascular tone. J. Pharmac. Exp. Ther. 247, 882-888.
14. Schiele J. O. and Schwabe U. (1994) Characterization of the adenosine receptor in microvascular coronary endothelial cells. Eur. J. Pharmacol. 269, 51-58.
15. Schültz R. and Triggle C. R. (1994) Role of NO in vascular smooth muscle and cardiac muscle function. Trends Pharmac. Sci. 15, 255-259.
16. Shah M. A. and Lewis M. J. (1993) Modulation of myocardial contraction by endocardial and coronary vascular endothelium. Trends Cardiovasc. Med. 3, 98-103.